30 May 2022 - The Biosafety Council issues a positive advice (with conditions) for this trial
File:
Trial reference:
A Phase 3 Multinational, Randomized, Double-Blind, Placebo-Controlled Systemic Gene Delivery Study to Evaluate the Safety and Efficacy of SRP-9001 in Subjects With Duchenne Muscular Dystrophy (EMBARK)